Performance status is a standardized score doctors use to describe how well a patient can carry out everyday activities despite their illness. It captures things like whether you can work, care for yourself, walk around, or need help with basic tasks. Oncologists rely on it to gauge how aggressive a treatment a patient can tolerate and to estimate prognosis.
Origin
The concept was introduced by oncologist David Karnofsky in 1948 to measure the functional impact of chemotherapy on cancer patients. The Eastern Cooperative Oncology Group (ECOG) later developed a simpler five-point scale in 1960, which along with the Karnofsky Performance Scale (KPS) remains in standard use today.
Significance in Asbestos Context
For someone diagnosed with mesothelioma or advanced lung cancer, performance status is one of the single most important factors in deciding which treatments are realistic. Surgery options like pleurectomy/decortectomy or extrapleural pneumonectomy, aggressive chemotherapy combinations, and immunotherapy regimens are typically offered only to patients with a strong performance status (ECOG 0–1 or KPS 70+). It also appears throughout your medical records and is cited by expert witnesses to describe how the disease has affected your daily life, which can support both medical decision-making and damages in a legal claim. A declining performance status over time is documented evidence of how the disease is progressing.
Example Sentence
The oncologist noted my husband's ECOG performance status had dropped from 1 to 2 over three months, which influenced her recommendation to switch from combination chemotherapy to a less intensive regimen.
Related Terms
Karnofsky Performance Scale, ECOG Score, Prognosis, Quality of Life, Palliative Care, Clinical Trial Eligibility
Notes
- Ask your oncologist what your current ECOG or Karnofsky score is and request that it be recorded at each visit. These notations create a timeline of functional decline.
- Performance status often determines eligibility for clinical trials; if you are interested in a trial, ask whether your score meets the entry criteria and whether anything can be done to improve it (nutrition, physical therapy, treating anemia or pain).
- Keep your own log of daily activities you can and cannot do (walking distance, stairs, dressing, cooking). This real-world detail supplements the clinical score and can be valuable for both treatment discussions and legal damages testimony.
- A sudden drop in performance status warrants prompt evaluation; it may reflect treatable issues like infection, dehydration, anemia, or pain rather than disease progression alone.
In the research library
228 studies in our medical research library mention Performance Status in the title or abstract. Among the most cited:
- Programmed cell death 1 ligand 1 (PD-L1) expression is associated with poor prognosis of malignant pleural mesothelioma patients with good performance statusE. Rrapaj, L. Giacometti, P. Spina, et al, 2021 · Pathology · cited 8 times
- Stage distribution and performance status of newly diagnosed patients in a UK regional mesothelioma centreS. Khan, M. Evison, M. Alaloul, et al, 2014 · Lung Cancer · cited 2 times
- Association of tumour mutational burden with outcomes in patients with advanced solid tumours treated with pembrolizumab: prospective biomarker analysis of the multicohort, open-label, phase 2 KEYNOTE-158 studyA. Marabelle, M. Fakih, J. Lopez, et al, 2020 · The Lancet. Oncology · cited 2,186 times
- Bevacizumab for newly diagnosed pleural mesothelioma in the Mesothelioma Avastin Cisplatin Pemetrexed Study (MAPS): a randomised, controlled, open-label, phase 3 trialG. Zalcman, J. Mazieres, J. Margery, et al, 2016 · Lancet · cited 762 times
- Malignant mesotheliomaB.W. Robinson, A.W. Musk, R.A. Lake, 2005 · Lancet · cited 606 times
The journals that publish most on it: The Lancet. Oncology (17), Journal of Thoracic Oncology (13), Lung Cancer (12).
Category: Diagnostic Tools & Biomarkers · All Lexicon terms A–Z
This page is provided for general informational purposes and does not constitute legal advice. Every asbestos case turns on its own facts, exposure history, diagnosis, deadlines, available evidence, and applicable law. Reviewing this page does not create an attorney-client relationship. For advice about your specific situation, call 833-4-ASBESTOS for a free case review.